Quantinno Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.19M | Buy |
15,609
+5,513
| +55% | +$2.89M | 0.04% | 617 |
|
|
2025
Q1 | $6.4M | Buy |
10,096
+5,065
| +101% | +$3.21M | 0.04% | 545 |
|
|
2024
Q4 | $3.58M | Sell |
5,031
-2,442
| -33% | -$1.74M | 0.04% | 612 |
|
|
2024
Q3 | $7.86M | Buy |
7,473
+2,798
| +60% | +$2.94M | 0.1% | 196 |
|
|
2024
Q2 | $4.91M | Buy |
4,675
+637
| +16% | +$670K | 0.09% | 246 |
|
|
2024
Q1 | $3.89M | Buy |
4,038
+985
| +32% | +$948K | 0.08% | 274 |
|
|
2023
Q4 | $2.68M | Sell |
3,053
-213
| -7% | -$187K | 0.09% | 271 |
|
|
2023
Q3 | $2.69M | Buy |
3,266
+857
| +36% | +$705K | 0.12% | 196 |
|
|
2023
Q2 | $1.73M | Sell |
2,409
-68
| -3% | -$48.9K | 0.1% | 261 |
|
|
2023
Q1 | $2.04M | Buy |
2,477
+500
| +25% | +$411K | 0.13% | 186 |
|
|
2022
Q4 | $1.43M | Buy |
1,977
+1,372
| +227% | +$990K | 0.11% | 274 |
|
|
2022
Q3 | $417K | Sell |
605
-24
| -4% | -$16.5K | 0.05% | 418 |
|
|
2022
Q2 | $372K | Sell |
629
-15
| -2% | -$8.87K | 0.05% | 406 |
|
|
2022
Q1 | $450K | Buy |
+644
| New | +$450K | 0.07% | 323 |
|